Protective role of melatonin against adipose-hepatic metabolic comorbidities in experimentally induced obese rat model

BACKGROUND: Adipose and hepatic metabolic dysfunctions are critical comorbidities that also aggravate insulin resistance in obese individuals. Melatonin is a low-cost agent and previous studies suggest that its use may promote metabolic health. However, its effects on some comorbidities associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Obayemi, Mary J., Akintayo, Christopher O., Oniyide, Adesola A., Aturamu, Ayodeji, Badejogbin, Olabimpe C., Atuma, Chukwubueze L., Saidi, Azeezat O., Mahmud, Hadiza, Olaniyi, Kehinde S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654266/
https://www.ncbi.nlm.nih.gov/pubmed/34879109
http://dx.doi.org/10.1371/journal.pone.0260546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654266/
https://www.ncbi.nlm.nih.gov/pubmed/34879109
http://dx.doi.org/10.1371/journal.pone.0260546

Ejemplares similares